title: 17β-estradiol rapidly attenuates P2X3 receptor-mediated peripheral pain signal transduction via ERα and GPR30.
abstract: Estrogen has been reported to affect pain perception, although the underlying mechanisms remain unclear. In this investigation, pain behavior testing, patch clamp recording, and immunohistochemistry were used on rats and transgenic mice to determine which estrogen receptors (ERs) and the related signaling pathway are involved in the rapid modulation of estrogen on P2X3 receptor-mediated events. The results showed that 17β-estradiol (E2) rapidly inhibited pain induced by α,β-methylene ATP (α,β-me-ATP), a P2X1 and P2X3 receptor agonist in ovariectomized rats and normal rats in diestrus. The ERα agonist 4,49,499-(4-propyl-[1H]-pyrazole-1,3,5-triyl) trisphenol (PPT) and G protein-coupled receptor 30 (GPR30) agonist G-1 mimicked the estrogen effect, whereas the ERβ agonist diarylpropionitrile (DPN) had no effect. In cultured rat dorsal root ganglion (DRG) neurons, PPT and G-1 but not DPN significantly attenuated α,β-me-ATP-mediated currents, with the dose-response curve of these currents shifted to the right. The inhibitory effect of E2 on P2X3 currents was blocked by G-15, a selective antagonist to the GPR30 estrogen receptor. E2 lacked this effect in DRG neurons from ERα-knockout mice but partly remained in those from ERβ-knockout mice. The P2X3 and GPR30 receptors were coexpressed in the rat DRG neurons. Furthermore, the ERK1/2 inhibitor U0126 reversed the inhibitory effect of E2 on α,β-me-ATP-induced pain and of PPT or G-1 on P2X3 receptor-mediated currents. The cAMP-protein kinase A (PKA) agonist forskolin, but not the PKC agonist phorbol-12-myristate-13-acetate (PMA), mimicked the estrogen-inhibitory effect on P2X3 receptor currents, which was blocked by another ERK1/2 inhibitor, PD98059. These results suggest that estrogen regulates P2X3-mediated peripheral pain by acting on ERα and GPR30 receptors expressed in primary afferent neurons, which probably involves the intracellular cAMP-PKA-ERK1/2 pathway.
authors.affiliation: Department of Physiology, School of Pharmacy, Second Military Medical University, Shanghai 200433, People’s Republic of China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Lu
authors.forename: Qian
authors.initials: Q
authors.lastname: Jiang
authors.forename: Lihua
authors.initials: L
authors.lastname: Yu
authors.forename: Zhan-ying
authors.initials: ZY
authors.lastname: Lu
authors.forename: Shuang-ping
authors.initials: SP
authors.lastname: Meng
authors.forename: Dingfeng
authors.initials: D
authors.lastname: Su
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Burnstock
authors.forename: Bei
authors.initials: B
authors.lastname: Ma
mesh_terms: D000818:Animals; D004031:Diestrus / Q000378:metabolism; D004958:Estradiol / Q000627:therapeutic use*; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism*; D005260:Female; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D010052:Ovariectomy; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*; D058477:Receptors, Purinergic P2X3 / Q000235:genetics / Q000378:metabolism*
chemical_list: D047628:Estrogen Receptor alpha; C520305:Gper1 protein, rat; D043562:Receptors, G-Protein-Coupled; D058477:Receptors, Purinergic P2X3; D004958:Estradiol